Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Depreciation & Amortization (CF) (2018 - 2025)

TELA Bio has reported Depreciation & Amortization (CF) over the past 8 years, most recently at $130000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $130000.0 for Q4 2025, down 23.98% from a year ago — trailing twelve months through Dec 2025 was $630000.0 (changed 0.32% YoY), and the annual figure for FY2025 was $630000.0, changed 0.32%.
  • Depreciation & Amortization (CF) for Q4 2025 was $130000.0 at TELA Bio, down from $153000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for TELA hit a ceiling of $175000.0 in Q2 2025 and a floor of $51000.0 in Q3 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $119500.0 (2023), compared with a mean of $115200.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 41.07% in 2023 and later surged 159.09% in 2024.
  • TELA Bio's Depreciation & Amortization (CF) stood at $61000.0 in 2021, then surged by 83.61% to $112000.0 in 2022, then crashed by 41.07% to $66000.0 in 2023, then surged by 159.09% to $171000.0 in 2024, then decreased by 23.98% to $130000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $130000.0 (Q4 2025), $153000.0 (Q3 2025), and $175000.0 (Q2 2025) per Business Quant data.